Advances in lipid management: empowering pharmacists to lower LDL-C to target

Three key takeaways

• Urgency to Treat: educate on the importance of lowering LDL-C to target in secondary prevention of ASCVD
• Lipid Management Guidelines: explain the ESC guidelines and changes to QOF 2025/26
• Optimal Treatment sequencing of ASCVD patients: discuss treatment options to lower LDL-C and importance of treatment sequencing